Multiple Biologics for Multiple T2 Diseases: A Pharmacoepidemiological Algorithm for Sorting Out Patients by Indication.
Fiche publication
Date publication
novembre 2023
Journal
Journal of asthma and allergy
Auteurs
Membres identifiés du Cancéropôle Est :
Pr JANKOWSKI Roger
Tous les auteurs :
Charriot J, Descamps V, Jankowski R, Maravic M, Bourdin A
Lien Pubmed
Résumé
Several biologics (Bx) and targeted synthetic drugs (TSD) exist to treat T2 diseases, including chronic spontaneous urticaria (CSU), severe asthma (SA), chronic rhinosinusitis with nasal polyposis (CRSwNP) or atopic dermatitis (AD).
Mots clés
T2 diseases, atopic dermatitis, biologics, nasal polyposis, severe asthma, urticaria
Référence
J Asthma Allergy. 2023 11 29;16:1287-1295